Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point.
about
Antiplatelet Therapy in Hemodialysis Patients Undergoing Percutaneous Coronary InterventionsEchocardiographic guidance for diagnostic and therapeutic percutaneous proceduresManaging Antiplatelet Therapy and Anticoagulants in Patients with Coronary Artery Disease and Atrial FibrillationGender differences in in-hospital clinical outcomes after percutaneous coronary interventions: an insight from a Japanese multicenter registryChange in hospital-level use of transradial percutaneous coronary intervention and periprocedural outcomes: insights from the national cardiovascular data registryRestrictive and liberal red cell transfusion strategies in adult patients: reconciling clinical data with best practice.Oral antiplatelet therapy for acute and chronic management of NSTE ACS: residual ischemic risk and opportunities for improvement.A random forest based risk model for reliable and accurate prediction of receipt of transfusion in patients undergoing percutaneous coronary intervention.Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding scores in ACS patients undergoing PCI: insights from a cohort of 4939 patients in ChinaMajor bleeding events in Jordanian patients undergoing percutaneous coronary intervention (PCI): Incidence, associated factors, impact on prognosis, and predictability of the CRUSADE bleeding risk score. Results from the First Jordanian PCR (PCR1)Justification of 150 mg clopidogrel in patients with high on-clopidogrel platelet reactivity.Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research ConsortiumPeriprocedural hemoglobin changes and myocardial injury in patients undergoing percutaneous coronary interventionPatterns of use and comparative effectiveness of bleeding avoidance strategies in men and women following percutaneous coronary interventions: an observational study from the National Cardiovascular Data Registry.Bleeding avoidance strategies. Consensus and controversyImplications of bleeding in acute coronary syndrome and percutaneous coronary intervention.Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry.Balancing the risks of bleeding and stent thrombosis: a decision analytic model to compare durations of dual antiplatelet therapy after drug-eluting stents.Targeting aspirin in acute disabling ischemic stroke: an individual patient data meta-analysis of three large randomized trials.A meta-analysis of sex-related differences in outcomes after primary percutaneous intervention for ST-segment elevation myocardial infarction.Precision medicine to improve use of bleeding avoidance strategies and reduce bleeding in patients undergoing percutaneous coronary intervention: prospective cohort study before and after implementation of personalized bleeding risks.Age-related differences in treatment strategies and clinical outcomes in unselected cohort of patients with ST-segment elevation myocardial infarction transferred for primary angioplastyAntiplatelet therapy in acute coronary syndromes: current agents and impact on patient outcomes.The association of in-hospital major bleeding with short-, intermediate-, and long-term mortality among older patients with non-ST-segment elevation myocardial infarctionPostdischarge Bleeding After Percutaneous Coronary Intervention and Subsequent Mortality and Myocardial Infarction: Insights From the HMO Research Network-Stent RegistryThe impact of vascular access for in-hospital major bleeding in patients with acute coronary syndrome at moderate- to very high-bleeding risk.Incidence and predictors of radial artery occlusion associated transradial catheterization.Duration of eptifibatide infusion after percutaneous coronary intervention and outcomes among high-risk patients with non-ST-segment elevation acute coronary syndrome: insights from EARLY ACS.Design and rationale of the AngioSeal versus the Radial approach In acute coronary SyndromE (ARISE) trial: a randomized comparison of a vascular closure device versus the radial approach to prevent vascular access site complications in non-ST-segmenTarget populations and relevant therapeutic end points to further improve outcomes in NSTEACS patients.TransRadial Education and Therapeutics (TREAT): shifting the balance of safety and efficacy of antithrombotic agents in percutaneous coronary intervention: a report from the Cardiac Safety Research Consortium.Oral antiplatelet therapy in the secondary prevention of atherothrombotic events.Effects of radial versus femoral artery access in patients with acute myocardial infarction: A large centre prospective registry.Percutaneous coronary intervention in treatment of multivessel coronary artery disease in patients with non-ST-segment elevation acute coronary syndromeTrends in major entry site complications from percutaneous coronary intervention (from the Dynamic Registry).Gender differences in risk profile and outcome of Middle Eastern patients undergoing percutaneous coronary intervention.Decision-making: stenting in acute myocardial infarction.Successful reduction of surgeries secondary to arterial access site complications: a retrospective review at a single center with an extravascular closure device.Shock in acute myocardial infarction: the Cape Horn for trials?Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis.
P2860
Q26777116-67726A85-6B4A-496F-9F25-5D3752924EC8Q26862837-F1C08FB7-164D-42F8-8171-A6F945CA404BQ28080247-681BD590-9112-4C99-A594-DF0D7ABC936AQ28543166-93D4E6E8-5184-4E6B-9A2D-342D38655A46Q30829141-57DF5A8C-48D8-4524-BF78-C7221BA66F84Q30943711-B0D251DC-44E5-454B-99A7-7AF615AE0747Q33554381-A4C09770-3DD6-4994-83FC-780E8264EC28Q33590075-1F816418-8F14-4C99-8169-308397428CB3Q33615438-7505F8B8-8F0D-4AD7-8C58-C89223D9C998Q33814243-64D19199-EAF2-42B4-997A-1C49174C0CE0Q34014099-3325C68D-9728-42B0-B3ED-41F9DAEE1C89Q34492675-02E90E7C-B996-42F7-88D0-63FDF5DEA4B7Q34621093-0B30D632-687A-47DE-AFD1-06BC2C63480CQ34633291-CA974946-45EC-49E3-8754-AD628FA5A452Q35079519-742951EE-EE65-40A4-9AB1-77B3BE86C47BQ35193938-FA429AAC-E00C-4B1B-82F8-8B70F390A42AQ35416397-86E19A36-3BF9-4240-ACFD-106D8171D68AQ35530065-04A07A6C-6A8E-4DC7-AC1F-AC66F3ACCFAEQ35599689-6D61E5B0-27FD-4968-B6B4-20BE319E478AQ35605601-85019B58-1CD8-45C0-B635-434A232D21C1Q35714397-724A5062-C3AC-4559-AACE-CD5096CA6B99Q36095614-EB7F88A3-174D-40B7-B554-7B09839C6DE7Q36160606-60DB565A-12C9-4959-BB25-DBC43CF6B74FQ36162429-EE7137D7-09FF-48B4-B834-1A9B6510B3E0Q37040299-68F140FF-EDB7-47C5-BD59-697A9AF46A08Q37147326-99924ED2-4DC9-4C5B-8C34-BF77F6AABA3EQ37246091-A26A2235-A11A-4D24-8177-8F9F1F7F4EF3Q37291851-A27CFF8B-5B9D-4B66-9518-3949A516BF3DQ37426083-731B2730-EAFE-4A74-893F-6D680CD09A27Q37445883-7F12C171-2ADA-4584-9047-F5B130DAA6CBQ37457934-F47C16BE-99D7-4699-B87D-2254F71A0D03Q37492564-0A01032C-A6D3-479B-B309-122C05208817Q37528146-D1393E31-4C14-4228-8C5B-8D6338226CBCQ37561885-B6D309E6-9E12-4C1A-8E00-FFEA10EC48E2Q37624652-9FFFF141-CC67-4048-ABA3-2905555B3D9FQ37670723-19BC1AE3-84B3-4A68-944E-954FFE7A8FF1Q37749818-AE2A5F55-779A-4EA0-A8C3-CD2F7C450801Q37756348-9D9259B5-68B0-4BB0-A8D1-8842DCB05A0CQ37770822-19B42239-BFF1-44DB-8687-FE10267D60A8Q37868373-6DC0DEBA-A3C8-45E9-ADCC-506D5CD8FBAC
P2860
Periprocedural bleeding and 1-year outcome after percutaneous coronary interventions: appropriateness of including bleeding as a component of a quadruple end point.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Periprocedural bleeding and 1- ...... nent of a quadruple end point.
@en
Periprocedural bleeding and 1- ...... nent of a quadruple end point.
@nl
type
label
Periprocedural bleeding and 1- ...... nent of a quadruple end point.
@en
Periprocedural bleeding and 1- ...... nent of a quadruple end point.
@nl
prefLabel
Periprocedural bleeding and 1- ...... nent of a quadruple end point.
@en
Periprocedural bleeding and 1- ...... nent of a quadruple end point.
@nl
P2093
P50
P1476
Periprocedural bleeding and 1- ...... nent of a quadruple end point.
@en
P2093
Franz-Josef Neumann
Gjin Ndrepepa
Melchior Seyfarth
Peter B Berger
P304
P356
10.1016/J.JACC.2007.10.040
P407
P577
2008-02-01T00:00:00Z